Improvements in technique appear to allow endarterectomy to be performed below the inguinal ligament with a reasonable initial success rate. In this series it is 95 %. If the occluded segment is of limited length this operation is preferred to the femoro-popliteal bypass graft. In practice, however, the arteriogram often gives an inadequate assessment of the length of artery requiring endarterectomy. This is frequently much longer than is apparent radiologically.
Discussion
Improvements in technique appear to allow endarterectomy to be performed below the inguinal ligament with a reasonable initial success rate. In this series it is 95 %. If the occluded segment is of limited length this operation is preferred to the femoro-popliteal bypass graft. In practice, however, the arteriogram often gives an inadequate assessment of the length of artery requiring endarterectomy. This is frequently much longer than is apparent radiologically.
When the superficial femoral artery alone is the site of operation, the common femoral and popliteal arteries must be carefully scrutinized on the arteriograms. If any doubt exists about their adequacy they must be explored at operation, because disease above or below the superficial femoral endarterectomy may cause primary failure. When aorto-iliac occlusive disease is present in addition to disease below the inguinal ligament endarterectomy can be performed simultaneously above and below the inguinal ligament. In short occluded segments we prefer to use direct endarterectomy without stripping. In long occluded segments, if the atheromatous material separates easily, we use a stripper. Arteries are stripped under direct vision to ensure that no damage is done to the outer wall of the vessel, and any serious resistance to stripping requires a further arteriotomy. In all cases, whether stripping is done or not, the lowest limit of the endarterectomy is directly visualized through an arteriotomy, and the distal intima anchored where required.
We believe that any arteriotomy distal to the common femoral artery should be closed with a vein or Dacron patch, and some common femoral arteriotomies also require this. Some surgeons recommend arteriography on the operating-table, after stripping to ensure that no atheromatous fragments are left in the arterial lumen (Wylie, Binkley, and Albo, 1964) . We have not practised this. It would certainly appear to be a wise precaution where stripping was difficult, but we prefer open endarterectomy under direct vision in these conditions.
The primary results have been encouraging, and all of those cases presenting with claudication were relieved of their symptoms. In the group of seven patients presenting with gangrene or rest pain the alternative to arterial reconstruction was a major amputation, and all but one were saved this. , probably involves the diffusion of activator from the plasma into fibrin, with activation of intrinsic clot plasminogen; the resulting plasmin is in close association with fibrin, which is lysed-the process of thrombolysis. In plasma, on the other hand, plasmin produced by physiological levels of activator is neutralized by antiplasmin and plasma proteins are protected from digestion.
With high levels of plasminogen activator in the circulationfor example, in certain haemorrhagic states or during thrombolytic therapy-rapid conversion of plasma plasminogen to plasmin results in temporary overwhelming of the antiplasmin mechanism, with the appearance of free plasmin in the circulation-hyperplasminaemia. The consequences of hyperplasminaemia include digestion of coagulation factors, including fibrinogen, factor V, prothrombin, and antihaemophilic globulin, and defective fibrin polymerization due to the presence in the circulation of fibrinogen breakdown products which interfere with the conversion of fibrin monomer to fibrin polymer, and hence prolong the thrombin clotting-time and the one-stage prothrombin time (Fletcher et al., 1964) . The object of thrombolytic therapy is to increase plasma activator levels, and hence plasma thrombolytic activity, with the object of removing occlusive thrombus before distal tissue necrosis or other deleterious effects have occurred ; a degree of hyperplasminaemia has usually to be accepted as an inevitable concomitant of a significant increase in activator levels. Nicotinic acid owes its fibrinolytic activity to its ability to increase plasma activator levels (Sawyer et al., 1960) , though the mechanism by which it does so is not known. In the present assessment of Complamin as a fibrinolytic agent, factors studied after its administration included plasma fibrinolytic activity, plasminogen and fibrinogen levels, thrombin clotting-time and one-stage prothrombin time, and type and incidence of side-effects.
Materials and Methods
Complamin was made available by Edinburgh Pharmaceutical Industries as ampoules containing 300 mg. in 2 ml. and 150-mg. tablets. The minimum dosage of the intravenous preparation suggested by the manufacturers is 300 mg. t.i.d., and of the tablets 150 mg. t.i.d.
Human fibrinogen was prepared from expired bank plasma by a phosphate buffer method (Biggs and Macfarlane, 1962 Douglas (1962) .
Fibrin plate tests were performed as described by Nilsson and Olow (1962 Fig. 2 , where it will be seen that there is a progressive reduction in euglobulin lysis activity induced by the second and third injections. Another healthy subject was given a daily intravenous injection of 150 mg. of Complamin for five days. The euglobulin lysis response is shown in Fig. 3 Table, where it will be seen that with two tablets there was a minor increase in euglobulin lysis activity in Subjects 1 and 3, but no change in Subjects 2 and 4. With four tablets, Subject 2 showed no change, euglobulin lysis activity doubled in Subject 4, and showed a significant increase in Subject 3. With two tablets, where a rise in euglobulin lysis activity was seen, it was noted in the 30-minute samples but had subsided at 60 minutes. With four tablets the effect seemed to be somewhat longerlasting, being noted in both Subjects 3 and 4 at 120 minutes. Intravenous Infusions.-An intravenous infusion of Complamin was given to two subjects with very similar results. The effects of the infusion in one of the subjects are shown in Fig. 4 The mechanism by which Complamin produces increased lcvels of fibrinolytic activity in the circulation is not clear, though it is shared by some other vaso-active drugs-for example, adrenaline and Pitressin (von Kaulla, 1963) . Histamine, however, which produces vasodilatation, does not cause increased plasma fibrinolytic activity (Weiner et (Fletcher et al., 1964) It has long been established that obesity may lead to development of diabetes mellitus, and also that weight reduction often leads to a complete remission of this diabetes mellitus (Newburg and Conn, 1939) . However, since diabetes in the obese, as well as other diabetic states, can be corrected by insulin, its basis may well be a relative insulin deficiency, whether from lack of production, excessive utilization, or both. Yet in obese diabetics measurement of the serum insulin-like activity usually shows normal or high levels, which at first sight does not seem to fit this hypothesis (Bornstein and Lawrence, 1951; Vallance-Owen et al., 1955 ; Seltzer and Smith, 1959; Steinke et al., 1961a Steinke et al., , 1962 Samaan et al., 1962b) . The present studies were therefore undertaken to try to clarify some of the factors affecting insulin activity in obesity.
In obese mice have been found hypertrophied pancreatic islet beta-cells, raised levels of serum insulin-like activity, both by bioassay and immunoassay, and also decreased tissue responsiveness to insulin; these features being found both in genetic obesity and in that induced by hypothalamic lesions (Christophe et al., 1959; Hales and Kennedy, 1963; Sneyd, 1964) . And, correspondingly, in obese humans there has also been found evidence both of hyperinsulinism and of insulin resistance; for the former from serum insulin assays (Karam et al., 1963; Samaan and Fraser, 1963) and from forearm metabolic studies (Rabinowitz and Zierler, 1962) , and for the latter from intravenous-insulin-tolerance tests, both by standard techniques (Fraser et al., 1962) and by localized forearm techniques (Rabinowitz and Zierler, 1962) .
As Randle et al. (1963) have suggested, the diabetic tendency in obesity, as well as that in starvation and Cushing's syndrome, may arise from impairment of the action of insulin by the increased concentration of fat metabolites prevailing in these states. Certainly there are raised levels of serum free fatty acids in obesity (Gordon, 1960; Corvilain et al., 1961 ; r Opie and Walfish, 1963) , as well as in starvation where ketosis also prevails (Kekwick et al., 1959) ; and the action of insulin on tissue is known to be impaired either by raised free fatty acid levels (Williamson and Krebs, 1961 ; Shipp et al., 1961) , or by increased concentrations of ketone bodies (Felts et al., 1964) . But other factors must also be involved ; since starvation, while indeed inducing in normal subjects a mild diabetes, can in the established diabetic considerably lessen his hyperglycaemia (Gephart et al., 1917; Allen, 1922) . Presumably starvation
